Your session is about to expire
← Back to Search
Physical Activity Coaching for Parkinson's Disease (Engage-PD Trial)
Phase 1
Waitlist Available
Research Sponsored by Teachers College, Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
Engage-PD Trial Summary
This trial is testing a new program to help people with early-mid stage Parkinson's disease to get more exercise. A physical or occupational therapist will provide one-on-one coaching to help individuals with early-mid stage Parkinson's disease to facilitate and optimize exercise uptake.
Who is the study for?
The Engage-PD trial is for people with early to mid-stage Parkinson's disease who can walk indoors and outdoors without help or devices, have passed a physical activity readiness test or got medical clearance, and have a neurologist-confirmed diagnosis. It's not for those with musculoskeletal injuries that stop them from exercising or other neurological conditions like stroke.Check my eligibility
What is being tested?
This study tests a telehealth-delivered physical activity coaching program led by therapists. The goal is to provide personalized support to encourage exercise as part of self-management for Parkinson's patients, based on prior research in similar diseases.See study design
What are the potential side effects?
Since the intervention involves physical activity coaching rather than medication, side effects are minimal but may include typical exercise-related issues such as muscle soreness or fatigue.
Engage-PD Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Brunel Lifestyle Physical Activity Questionnaire
Self-Efficacy for Exercise Scale
Secondary outcome measures
Acceptability questionnaire (open-ended questions)
Brief Pain Inventory
International Physical Activity Questionnaire (Short-Form Phone version)
+4 moreEngage-PD Trial Design
1Treatment groups
Experimental Treatment
Group I: Physical Activity CoachingExperimental Treatment1 Intervention
Participants will receive up to 5 coaching sessions by a physical or occupational therapist. The intervention will focus on facilitating physical activity engagement and development of specific and measurable goals. The recommended program will be individualized to each participant but will primarily focus on increasing general physical activity (e.g. steps per day) as well as engagement in moderate intensity aerobic exercise a minimum of three times per week. At the follow up sessions the therapist will review progress with the current exercise plan and progress and discuss barriers and facilitators for exercise engagement. Participants will have the option to use a Fitbit or other device to monitor their heart rate and physical activity during the course of the intervention period.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Physical Activity Coaching
2017
Completed Phase 2
~20
Find a Location
Who is running the clinical trial?
Teachers College, Columbia UniversityLead Sponsor
24 Previous Clinical Trials
5,757 Total Patients Enrolled
Columbia UniversityOTHER
1,439 Previous Clinical Trials
2,448,719 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a muscle or bone injury that would stop you from taking part in an exercise program.You have a neurological condition such as a stroke or other disorder.
Research Study Groups:
This trial has the following groups:- Group 1: Physical Activity Coaching
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Parkinson's Disease Patient Testimony for trial: Trial Name: NCT04922190 — Phase 1
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger